000 01507 a2200469 4500
005 20250515023332.0
264 0 _c20060628
008 200606s 0 0 eng d
022 _a0009-9163
024 7 _a10.1111/j.1399-0004.2006.00590.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSlowik, A
245 0 0 _aParaoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis.
_h[electronic resource]
260 _bClinical genetics
_cApr 2006
300 _a358-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAlleles
650 0 4 _aAmyotrophic Lateral Sclerosis
_xepidemiology
650 0 4 _aAryldialkylphosphatase
_xgenetics
650 0 4 _aCase-Control Studies
650 0 4 _aCholesterol, LDL
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenotype
650 0 4 _aHazardous Substances
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLeukocytes
_xcytology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolymorphism, Genetic
700 1 _aTomik, B
700 1 _aPartyka, D
700 1 _aTuraj, W
700 1 _aPera, J
700 1 _aDziedzic, T
700 1 _aSzermer, P
700 1 _aFiglewicz, D A
700 1 _aSzczudlik, A
773 0 _tClinical genetics
_gvol. 69
_gno. 4
_gp. 358-9
856 4 0 _uhttps://doi.org/10.1111/j.1399-0004.2006.00590.x
_zAvailable from publisher's website
999 _c16234094
_d16234094